Smith+Nephew’s revenue rebound: A 3-year comparison

Although Smith+Nephew’s overall first quarter revenue has grown since the same period in 2019, orthopedic revenue is still catching up to pre-pandemic figures.

Advertisement

Here’s a year-over-year comparison of Smith+Nephew’s first-quarter performance in the last three years:

Q1 2021
Revenue: $1.3 billion
Total orthopedic sales: $540 million
Knee sales: $212 million
Hip sales: $154 million
Trauma sales: $149 million

Q1 2020
Revenue: $1.1 billion
Total orthopedic sales: $497 million
Knee sales: $230 million
Hip sales: $137 million
Trauma sales: $109 million

Q1 2019
Net sales: $1.2 billion
Total orthopedic sales: $546 million
Knee sales: $261 million
Hip sales: $152 million
Trauma sales: $119 million

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 5 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.